Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions

Pain Med. Jan-Feb 2006;7(1):92-5. doi: 10.1111/j.1526-4637.2006.00101.x.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial

MeSH terms

  • Adult
  • Antidepressive Agents / therapeutic use
  • Antimanic Agents / therapeutic use
  • Brain / drug effects
  • Brain / metabolism
  • Brain / physiopathology
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / physiopathology
  • Depressive Disorder, Major / psychology
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Electroconvulsive Therapy
  • Excitatory Amino Acid Antagonists / pharmacology*
  • Female
  • Humans
  • Injections, Intravenous
  • Ketamine / administration & dosage*
  • Ketamine / adverse effects
  • Male
  • Receptors, N-Methyl-D-Aspartate / drug effects
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology
  • Treatment Outcome

Substances

  • Antidepressive Agents
  • Antimanic Agents
  • Excitatory Amino Acid Antagonists
  • Receptors, N-Methyl-D-Aspartate
  • Ketamine